TY  - GEN
AU  - Vergote,I B
AU  - Lund,B
AU  - Peen,U
AU  - Umajuridze,Z
AU  - Mau-Sorensen,M
AU  - Kranich,A
AU  - Van Nieuwenhuysen,E
AU  - Haslund,C
AU  - Nottrup,T
AU  - Han,S N
AU  - Concin,N
AU  - Unger,T J
AU  - Chai,Y
AU  - Au,N
AU  - Rashal,T
AU  - Joshi,A
AU  - Crochiere,M
AU  - Landesman,Y
AU  - Shah,J
AU  - Shacham,S
AU  - Kauffman,M
AU  - Mirza,M R
TI  - Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies
SN  - 1095-6859
PY  - 2020///0505
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Cohort Studies
KW  - Female
KW  - Genital Neoplasms, Female
KW  - drug therapy
KW  - Humans
KW  - Hydrazines
KW  - administration & dosage
KW  - Karyopherins
KW  - antagonists & inhibitors
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Neoplasm Recurrence, Local
KW  - Progression-Free Survival
KW  - Receptors, Cytoplasmic and Nuclear
KW  - Triazoles
KW  - Exportin 1 Protein
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ygyno.2019.11.012
ER  -